Pacira | PCRX - Ebit

金融业

USD

USD 1.21B

现金及等价物

USD 144.31M

USD 54.62M

USD 514.96M

USD 108.79M

USD 372.19M

USD 3.19M

USD 38.71M

790

EPS每股收益

USD 0.6

股本和储备

USD 653.89M

USD 142.25M

债务利息支出

USD 3.89M

USD 2.3M

USD 367.66M

USD 1.19B

USD 1.64M

USD 193.68M

USD 3.19M

普通股股本

USD 41.12M

52.68

USD 571K

USD 177M

销售和管理费用

USD 91.87M

USD 150.37M

贸易债权人

USD 14.01M

应收帐款人

USD 124.07M

	Ebit	更改		日
Astellas Pharma	JPY 48.57B		85.97B	2026-03
Bristol-Myers Squibb	USD 3.56B		90M	2026-03
Cara Therapeutics	USD -5.94M		3.55M	2025-09
Coherus Biosciences	USD -39.08M		3.65M	2025-12
Heron Therapeutics	USD 38K		3.83M	2025-12
Ironwood Pharmaceuticals	USD 33.22M		7.58M	2024-12
J&J	USD 6.62B		1.51B	2026-03
Ligand Pharmaceuticals	USD 158.89M		115.32M	2025-09
Nektar Therapeutics	USD -19.09M		15.26M	2025-12
Novo Nordisk	DKK 32.38B		1.7B	2025-12
Omeros	USD -48.15M		7.25M	2023-09
Pacira	USD 3.19M		9.96M	2025-12
Perrigo	USD 84.4M		9M	2025-12
Pfizer	USD 4.65B		71M	2025-12
Supernus Pharmaceuticals	USD 13.82M		74.01M	2025-12
Teva Pharmaceutical Industries	USD 758M		181M	2026-03
Xeris Pharmaceuticals	USD 16.77M		8.88M	2025-12
Xoma	USD -10.08M		4.4M	2024-06
Zoetis	USD 835M		140M	2025-12